ATP5IF1 and carcinoma: Finally, we should stress that, although we pioneered the idea of IF1 as a pro-oncogenic mitochondrial protein [41] promoting metabolic reprogramming of carcinomas to an enhanced glycolytic phenotype by the inhibition of ATP synthase [2,3,23], this terminology cannot be generalized for IF1 and should be used with caution.